logo

For the Inventor, By the Inventor

Seoul, South Korea

Kyung-Soo Hahm

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Chosun University, Bioleaders Corporation, Korea Research Institute of Bioscience and Biotechnology. Active years: 2004-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyung-Soo Hahm. Retrieved from https://idiyas.com/inventor/kyung-soo-hahm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal3 out of 120 
 
Chosun University
 patents
silverMedal2 out of 25 
 
Bioleaders Corporation
 patents
bronzeMedal1 out of 334 
 
Korea Research Institute of Bioscience and Biotechnology
 patents
where one patent can have more than one assignee

Years Active: 2004-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 8410046 - [object Object] (2013-04-02),
2. 8080402 - Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase (2011-12-20),
3. 7255855 - Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase (2007-08-14),
4. 6800727 - Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof (2004-10-05),

Title: Innovations of Kyung-Soo Hahm

Introduction

Kyung-Soo Hahm is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of antibiotic peptides, holding a total of four patents. His work focuses on developing safer and more effective antibiotics derived from ribosomal proteins.

Latest Patents

One of his latest patents involves a new antibiotic peptide derived from ribosomal protein L1, RPL1. This invention presents an antibiotic peptide with a specific amino acid sequence that has been modified to reduce cytotoxicity while enhancing antibacterial activity. Another significant patent details a method for expressing peptide antibiotics P5 and Anal3 on microbial surfaces. This innovative method allows for the mass production of these antibiotics without the need for purification, showcasing high industrial applicability.

Career Highlights

Kyung-Soo Hahm has worked with prominent organizations such as Bioleaders Corporation and Chosun University. His experience in these institutions has contributed to his expertise in antibiotic research and development.

Collaborations

He has collaborated with notable colleagues, including Moon-Hee Sung and Seung-Pyo Hong, to advance his research in antibiotic peptides.

Conclusion

Kyung-Soo Hahm's innovative work in antibiotic peptides demonstrates his commitment to improving healthcare through safer and more effective treatments. His contributions are paving the way for advancements in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…